Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Compass Therapeutics, Inc. CMPX

Set alert

Price alert · CMPX

All alert types
0.75 USD -0.02 -2.27%

As of Nov 3, 2:28 PM ET

Bid
0.75 × 2
Ask
0.75 × 6
0.75 Day range 0.7922
0.73 52-week range 6.88
YTD
-86.03%
1 year
-79.94%
Open
0.7833
Prev close
0.7675
Mkt cap
135.26M
Vol
854.16K
Avg vol
4.25M
EPS
-0.39
P/E
0.00
Div yield
0.00%
More statistics
Low
0.75
High
0.7922
Forward P/E
-10.86
Beta
1.30
Short ratio
12.39
Inst. own
88.00%
Dividend
0.00
Ex-div date
50-d avg
5.68
200-d avg
4.58
1y target
13.64

YTD chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Jan 5, 2026Rating: William Blair · — → Outperform
  • Jan 6, 2026Rating: D. Boral Capital · Buy → Buy
  • Mar 24, 2026Rating: Guggenheim · Buy → Buy
Signals (23)
NameDateAgo
MACD: Buy SignalOct 9, 20263 weeks ago
RSI: OversoldSep 22, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
SMA: BearishJul 24, 20263 months ago
SMA: BullishJul 23, 20263 months ago
SMA: BearishJul 22, 20263 months ago
SMA: BullishJul 21, 20263 months ago
SMA: BearishJul 17, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
SMA: BullishJul 2, 20264 months ago
MACD: Buy SignalMay 14, 20265 months ago
SMA: BearishApr 27, 20266 months ago
RSI: OversoldApr 27, 20266 months ago
MACD: Sell SignalApr 23, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 15, 20266 months ago
MACD: Buy SignalMar 25, 20267 months ago

Newest 20 of 23.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 13.64 +1718.8% upside
Target (low)
8.00
Target (mean)
13.64
Target (high)
30.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy13
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 16
  • 1 month ago 16
  • 2 months ago 16
  • 3 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CMPX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.09769-0.15 – -0.06-0.12+18.6%-600.00K0.0%13
Next quarter-0.09615-0.12 – -0.06-0.14+31.3%00.0%13
Current year-0.41077-0.62 – -0.17-0.42+2.2%1.14M0.0%13
Next year-0.4825-1.46 – -0.09-0.41077-17.5%53.31M+4583.0%12

Upgrades and downgrades

The latest rating changes

CMPX analyst upgrades and downgrades
DateFirmActionFromTo
Mar 24, 2026GuggenheimReiteratedBuyBuy
Jan 6, 2026D. Boral CapitalMaintainedBuyBuy
Jan 5, 2026William BlairInitiated—Outperform
Dec 3, 2025Cantor FitzgeraldInitiated—Overweight
Dec 3, 2025CitizensInitiated—Market Outperform
Dec 3, 2025Canaccord GenuityInitiated—Buy
Nov 5, 2025D. Boral CapitalMaintainedBuyBuy
Oct 6, 2025LifeSci CapitalInitiated—Outperform
Aug 12, 2025D. Boral CapitalMaintainedBuyBuy
Aug 12, 2025GuggenheimMaintainedBuyBuy
May 9, 2025GuggenheimMaintainedBuyBuy
Apr 28, 2025D. Boral CapitalMaintainedBuyBuy
Apr 22, 2025GuggenheimReiteratedBuyBuy
Apr 21, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 21, 2025D. Boral CapitalMaintainedBuyBuy
Apr 4, 2025HC Wainwright & Co.MaintainedBuyBuy
Apr 2, 2025GuggenheimReiteratedBuyBuy
Apr 2, 2025Leerink PartnersUpgradeMarket PerformOutperform
Apr 1, 2025D. Boral CapitalMaintainedBuyBuy
Feb 27, 2025D. Boral CapitalMaintainedBuyBuy
Feb 25, 2025D. Boral CapitalMaintainedBuyBuy
Feb 24, 2025GuggenheimInitiated—Buy
Feb 19, 2025Piper SandlerInitiated—Overweight
Feb 10, 2025JefferiesMaintainedBuyBuy
Jan 10, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Jan 8, 2025D. Boral CapitalMaintainedBuyBuy
Dec 23, 2024D. Boral CapitalInitiated—Buy
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 12, 2024HC Wainwright & Co.ReiteratedBuyBuy